HRP980097B1 - Combinatory compositions for the treatment of dementia - Google Patents
Combinatory compositions for the treatment of dementiaInfo
- Publication number
- HRP980097B1 HRP980097B1 HR980097A HRP980097A HRP980097B1 HR P980097 B1 HRP980097 B1 HR P980097B1 HR 980097 A HR980097 A HR 980097A HR P980097 A HRP980097 A HR P980097A HR P980097 B1 HRP980097 B1 HR P980097B1
- Authority
- HR
- Croatia
- Prior art keywords
- carbon atoms
- branched
- straight
- carbon chain
- alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19707655A DE19707655A1 (de) | 1997-02-26 | 1997-02-26 | Kombinationspräparat zur Anwendung bei Demenz |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP980097A2 HRP980097A2 (en) | 1998-12-31 |
HRP980097B1 true HRP980097B1 (en) | 2006-09-30 |
Family
ID=7821517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR980097A HRP980097B1 (en) | 1997-02-26 | 1998-02-25 | Combinatory compositions for the treatment of dementia |
Country Status (30)
Country | Link |
---|---|
US (1) | US6037347A (zh) |
EP (1) | EP0867192B1 (zh) |
JP (1) | JP4374440B2 (zh) |
KR (1) | KR100517186B1 (zh) |
CN (1) | CN100363005C (zh) |
AR (1) | AR011860A1 (zh) |
AT (1) | ATE295738T1 (zh) |
AU (1) | AU749278C (zh) |
BR (1) | BR9800766A (zh) |
CA (1) | CA2230350C (zh) |
CZ (1) | CZ298367B6 (zh) |
DE (2) | DE19707655A1 (zh) |
DK (1) | DK0867192T3 (zh) |
EE (1) | EE03387B1 (zh) |
ES (1) | ES2242243T3 (zh) |
HR (1) | HRP980097B1 (zh) |
HU (1) | HUP9800396A3 (zh) |
ID (1) | ID19941A (zh) |
IL (1) | IL123453A (zh) |
MY (1) | MY120530A (zh) |
NO (1) | NO327200B1 (zh) |
NZ (1) | NZ329839A (zh) |
PL (1) | PL191576B1 (zh) |
PT (1) | PT867192E (zh) |
RU (1) | RU2194508C2 (zh) |
SI (1) | SI0867192T1 (zh) |
SK (1) | SK284925B6 (zh) |
TR (1) | TR199800302A3 (zh) |
TW (1) | TW590772B (zh) |
ZA (1) | ZA981561B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ510683A (en) * | 1998-10-01 | 2003-09-26 | Novartis Ag | Sustained release oral formulations of rivastigmine |
US20040110776A1 (en) * | 2002-02-22 | 2004-06-10 | Iok-Hou Pang | Use of propentofylline to control intraocular pressure |
AU2003270446A1 (en) * | 2002-09-25 | 2004-04-19 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating alzheimer's disease and dementias of vascular origin |
US8481565B2 (en) | 2004-12-27 | 2013-07-09 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
WO2006118265A1 (ja) * | 2005-04-28 | 2006-11-09 | Eisai R & D Management Co., Ltd. | 抗痴呆薬を含有する組成物 |
EP4019018A1 (en) | 2015-09-11 | 2022-06-29 | Chase Pharmaceuticals Corporation | Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system |
RU2616247C1 (ru) * | 2016-03-28 | 2017-04-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) | Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3737433A (en) * | 1964-09-05 | 1973-06-05 | Albert Ag Chem Werke | Certain oxoalkyldimethylxanthines |
US3621096A (en) * | 1969-04-03 | 1971-11-16 | Univ North Carolina | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone |
DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
DE2856393C2 (de) * | 1978-12-27 | 1983-04-28 | Merz + Co GmbH & Co, 6000 Frankfurt | Arzneimittel zur Behandlung von Morbus Parkinson |
JPH062675B2 (ja) * | 1985-04-05 | 1994-01-12 | ヘキストジヤパン株式会社 | 記憶障害治療剤 |
DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
IL81610A (en) * | 1986-02-27 | 1990-12-23 | Roussel Uclaf | Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them |
GB8621870D0 (en) * | 1986-09-11 | 1986-10-15 | Beecham Group Plc | Active compounds |
FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
IL87861A0 (en) * | 1987-10-05 | 1989-03-31 | Pfizer | 4-aminopyridine derivatives |
WO1989002739A1 (en) * | 1987-10-05 | 1989-04-06 | Pfizer Inc. | 4-aminopyridine derivatives |
DE3817955A1 (de) * | 1988-05-27 | 1989-11-30 | Hoechst Ag | Tnf-inhibitor enthaltendes arzneimittel |
KR920703068A (ko) * | 1989-09-15 | 1992-12-17 | 폴 레이킨드 | 신경변성 질환의 치료방법 |
DE4236331A1 (de) * | 1992-10-28 | 1994-05-05 | Boehringer Ingelheim Kg | Synergistische Kombination |
US5783584A (en) * | 1995-12-11 | 1998-07-21 | Mayo Foundation For Medical Education And Research | THA analogs useful as cholinesterase inhibitors |
GB9612710D0 (en) * | 1996-06-18 | 1996-08-21 | Pfizer Ltd | Method of treatment |
-
1997
- 1997-02-26 DE DE19707655A patent/DE19707655A1/de not_active Withdrawn
-
1998
- 1998-02-16 EP EP98102620A patent/EP0867192B1/de not_active Expired - Lifetime
- 1998-02-16 DK DK98102620T patent/DK0867192T3/da active
- 1998-02-16 DE DE59812801T patent/DE59812801D1/de not_active Expired - Lifetime
- 1998-02-16 ID IDP980209A patent/ID19941A/id unknown
- 1998-02-16 SI SI9830775T patent/SI0867192T1/xx unknown
- 1998-02-16 ES ES98102620T patent/ES2242243T3/es not_active Expired - Lifetime
- 1998-02-16 AT AT98102620T patent/ATE295738T1/de not_active IP Right Cessation
- 1998-02-16 PT PT98102620T patent/PT867192E/pt unknown
- 1998-02-23 EE EE9800075A patent/EE03387B1/xx not_active IP Right Cessation
- 1998-02-24 TR TR1998/00302A patent/TR199800302A3/tr unknown
- 1998-02-24 SK SK240-98A patent/SK284925B6/sk not_active IP Right Cessation
- 1998-02-24 AR ARP980100810A patent/AR011860A1/es not_active Application Discontinuation
- 1998-02-24 TW TW087102577A patent/TW590772B/zh not_active IP Right Cessation
- 1998-02-24 CZ CZ0054098A patent/CZ298367B6/cs not_active IP Right Cessation
- 1998-02-24 AU AU56273/98A patent/AU749278C/en not_active Ceased
- 1998-02-24 NZ NZ329839A patent/NZ329839A/xx unknown
- 1998-02-24 RU RU98103712/14A patent/RU2194508C2/ru not_active IP Right Cessation
- 1998-02-24 CA CA002230350A patent/CA2230350C/en not_active Expired - Fee Related
- 1998-02-25 CN CNB981053289A patent/CN100363005C/zh not_active Expired - Fee Related
- 1998-02-25 IL IL12345398A patent/IL123453A/en not_active IP Right Cessation
- 1998-02-25 HR HR980097A patent/HRP980097B1/xx not_active IP Right Cessation
- 1998-02-25 HU HU9800396A patent/HUP9800396A3/hu unknown
- 1998-02-25 JP JP04305898A patent/JP4374440B2/ja not_active Expired - Fee Related
- 1998-02-25 BR BR9800766-1A patent/BR9800766A/pt not_active Application Discontinuation
- 1998-02-25 MY MYPI98000834A patent/MY120530A/en unknown
- 1998-02-25 ZA ZA981561A patent/ZA981561B/xx unknown
- 1998-02-25 NO NO19980786A patent/NO327200B1/no not_active IP Right Cessation
- 1998-02-25 US US09/030,207 patent/US6037347A/en not_active Expired - Lifetime
- 1998-02-26 PL PL325074A patent/PL191576B1/pl not_active IP Right Cessation
- 1998-02-26 KR KR10-1998-0006051A patent/KR100517186B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9305930A (es) | Derivados de piperidina, su preparacion y su aplicacion en terapeutica. | |
HRP980097B1 (en) | Combinatory compositions for the treatment of dementia | |
AU2721402A (en) | Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto | |
DE69425431T2 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
DE59610077D1 (de) | Phenyldihydrobenzofurane | |
PL315636A1 (en) | Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives | |
BR9813926A (pt) | Substituição de bioisóstero de catecol por indazol em compostos terapeuticamente ativos | |
BG103964A (en) | SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS | |
HUP0001122A2 (hu) | Farnezil-transzferáz-gátló kinazolinonok | |
ES8205554A1 (es) | Procedimiento de producir agentes orales de inhibicion de placas dentales | |
ATE228507T1 (de) | Substituierte 6-phenylphenanthridine | |
FI951454A0 (fi) | 1-(2-oksoasetyyli)piperidiini-2-karboksyylihappojohdannaiset monille lääkkeille resistenttien syöpäsolujen herkistäjinä | |
TR200000022T2 (tr) | 3-ya da 4-eşlenimli 4-(aminometil)-piperidin türevlerinin tek halkalı gastrokinetik benzamidleri. | |
BR9811093A (pt) | Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo) | |
ATE230404T1 (de) | Cyclohexyldihydrobenzofurane | |
FR2613365B1 (fr) | Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
DK0547545T3 (da) | Farmaceutisk præparat til inhibering af knogleresorption | |
BR9604907B1 (pt) | derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral com princìpios ativos. | |
MY159418A (en) | New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use | |
DK0760364T3 (da) | Amidinderivater og blodpladeaggregeringsinhibitor indeholdende samme | |
ATE209172T1 (de) | 1,3-diphenylpropanderivate mit hemmender aktivität gegen tyrosinase und verfahren zu deren herstellung | |
CO4940439A1 (es) | COMPUESTOS 4-AMINO-6,7-DISUSTITUIDOS-PIRIDO-[2,3-d] PIRIMI- DINA | |
IL117497A0 (en) | 17-Difluoromethylene estratriene derivatives and pharmaceutical compositions containing the same | |
BR0016463A (pt) | Compostos de n-(1-feniletil)-5-fenil-imidazol-2-amina, suas composições e usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090223 Year of fee payment: 12 |
|
PBON | Lapse due to non-payment of renewal fee |
Effective date: 20100226 |